Table 2.

Therapeutic efficacy of response and survival outcomes

Therapeutic response assessment	Evaluable patients (N = 31)
Confirmed objective response rate (ORR, n, %)	10 (32.3%)
Complete response (CR, n, %)	0
Partial response (PR, n, %)	10 (32.3%)
Stable disease (SD, n, %)	16 (51.6%)
Disease control rate (DCR, n, %)	26 (83.9%)
Clinical benefit rate (CBR n, %)	13 (41.9%)
Progressive disease (PD, n, %)	5 (16.1%)

CR complete response, PR partial response SD stable disease PD progressive disease, ORR objective response rate, DCR disease control rate, CBR clinical benefit rate